S1331 Phase II Trial of Weekly Erlotinib Dosing to Reduce Duodenal Polyp Burden Associated With Familial Adenomatous Polyposis. (October 2021) - Samadder, N. Jewel; Foster, Nathan; McMurray, Ryan; Burke, Carol A.; Stoffel, Elena; Kanth, Priyanka; Das, Rohit; Cruz-Correa, Marcia; Sanchez, Eduardo Vilar; Westover, Michelle; Richmond, Ellen; Della'Zanna, Gary; et al.